论文部分内容阅读
目的：研究不同年龄段乳腺癌的临床病理资料，评估国人不同年龄段患者的临床病理特征、免疫组化表达情况及临床分子分型的差异，对比分析不同年龄乳腺癌的生物学特征，研究乳腺癌的好发人群以便于进行重点防治和筛查，以及临床评估乳腺癌的进展、预后、指导临床治疗。
不同年龄女性乳腺癌临床病理特征分析
【摘 要】
：
目的：研究不同年龄段乳腺癌的临床病理资料，评估国人不同年龄段患者的临床病理特征、免疫组化表达情况及临床分子分型的差异，对比分析不同年龄乳腺癌的生物学特征，研究乳腺癌的好发人群以便于进行重点防治和筛查，以及临床评估乳腺癌的进展、预后、指导临床治疗。
【机 构】
：
沈阳 中国医科大学附属第一医院乳腺外科
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年4期
其他文献
α7 nicotinic acetylcholine receptor is a potential novel therapeutic target for hepatocellular carci
Objective: Nicotine and its associated nicotinic acetylcholine receptors (nAChRs) are believed to be involved in the progression of some solid carcinomas by regulating cell proliferation, apoptosis, t
Overexpression of RHOC predicts poor patient prognosis and promotes cell invasion in human cholangio
Objective: RHOC, as a member of the Ras superfamily of GTP-binding proteins, has been demonstrated to be involved in metastasis of many human malignancies;however, its role in human cholangiocellular
PRMT5 protects pancreatic cancer cells from apoptosis under hypoxia conditions via down-regulation o
Objective: Pancreatic cancer is one of the most intractable and fatal cancer and biologically characterized by high degrees of hypoxia.Here, we describe PRMT5 (protein arginine methltransferase 5), a
Objective: Increased serum fibrinogen has been reported to be associated with tumor progression and a poor outcome in various carcinomas.However, the association between preoperative serum fibrinogen
目的：探讨结肠癌肿瘤组织中MDSCs与肿瘤生长和演进中病理特征相关性研究，对于以MDSCs为靶点的胃肠道肿瘤的治疗具有重要意义。方法：收集10名健康志愿者(年龄30-50岁，平均年龄39岁)的正常结肠粘膜和45名新诊断的结肠癌患者(年龄35-80岁，平均年龄58岁)的肿瘤组织，用荧光标记的抗人Lin1、HLA DR、CD33及CD11b单克隆抗体标记肿瘤患者肿瘤组织和健康人的正常结肠粘膜，应用激光
Preclinical evaluation of AMG 337, a highly selective small molecule MET inhibitor, in hepatocellula
Objective: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide.Aberrant hepatocyte growth factor/MET signaling has been implicated in hepatocarcinogenesis, sug
会议
Safety and activity of blinatumomab for older patients (pts)with relapsed/refractory (R/R) B precurs
Objective: Treatment options for older pts with R/R ALL are limited.Blinatumomab is a bispecific T-cell engager(BiTE(R)) antibody construct that directs cytotoxic T cells to CD 19-expressing B cells,
Transcriptome sequencing Reveals the Potential Roles of driven genes in Chemotherapy-induced multidr
目的： Lung cancer is the leading cause of cancer-related deaths in China, currently, lun adenocarcinoma has become the major pathologic type of lung cancer.
目的：观察持续泵入恩度联合白蛋白紫杉醇及奈达铂方案治疗晚期鳞癌的疗效及毒副反应。方法：经病理组织学或细胞学证实的22例晚期鳞癌患者,采用持续泵入恩度3mg/d持续泵入,第1-7天,白蛋白紫杉醇200mg/m2,第一天。
会议
Objective: Patient with different age could affect the ability to manage the symptom distress and their level of quality of life (QOL).Furthermore, cancer-related fatigue (CRF) is the most experienced